Treatment Reality with Patients' Treatment Response in RE patients treated with low dose of PPIs via Web-based survey
Not Applicable
- Conditions
- Reflux esophagitis
- Registration Number
- JPRN-UMIN000017268
- Lead Sponsor
- AstraZeneca K.K. Medical
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
1.Subjects suspected of poor capability follow instructions of the survey.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of patient which all the item are selected to "1 day" or "nothing " of question 1,2,5,6 in GerdQ
- Secondary Outcome Measures
Name Time Method The item raised below is estimated. 1.The GerdQ score Mean of the whole questions of GerdQ 2.Healthy related QOL evaluation Mean of the SF-8TM J core 3.Patient's sentiment to a disease and treatment original questionnaire are which consiets of seven scale and enable to select more than two items at the same time. 4.The degree of the subjective symptom Sevenity of the subjective symptom (heartburn, acid reflux, epigastralgia, belch, nausea, vomit, dysphagia, epigastric distress (stomach leaning) and inappetence)